In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

France’s Drug Reimbursement System

Executive Summary

France’s current drug evaluation system involves two scales: one to determine absolute medical benefit (whether a drug or procedure will be reimbursed or not) and another additional medical benefit (which determines the rate of reimbursement.)

Advertisement

Related Content

France Seeks Stronger Cost-Effectiveness Tools To Lower Drug Prices, But Pan-European Bulk Buying May Come First

Topics

UsernamePublicRestriction

Register